science-361-6399-wastewater-treatment

A path to clean water

Several factors could explain the absence of pooling in this arena: the need for at least some market exclusivity in an environment with extremely high costs of product development, clinical trials, and regulatory approval; patent holders’ desire to retain control over their assets; and concerns over compromising commercial secrecy by collaborating with others.

By Klaus Kümmerer, et al. Jul 20th, 2018